Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Pendergrass, Sarah A ^a   Hayes, Everett ^b   Farina, Giuseppina ^b   Lemaire, Raphael ^b   Farber, Harrison W ^b   Whitfield, Michael L ^a   Lafyatis, Robert ^b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; BIOLOGICAL MARKER; CHEMOKINE RECEPTOR CCR1; GAMMA INTERFERON RECEPTOR 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 13 RECEPTOR ALPHA1; INTERLEUKIN 1BETA; INTERLEUKIN 6; JANUS KINASE 2; PROTEIN ALAS2; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD VESSEL INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOASSAY; INFLAMMATION; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; REAL TIME POLYMERASE CHAIN REACTION; SCREENING TEST; SYSTEMIC SCLEROSIS; UNINDEXED SEQUENCE; BLOOD; BLOOD VESSEL; CASE CONTROL STUDY; GENE EXPRESSION PROFILING; INJURY; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PULMONARY ARTERY;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD VESSELS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; HYPERTENSION, PULMONARY; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PULMONARY ARTERY; SCLERODERMA, SYSTEMIC;

EID: 77957914450     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012106     Document Type: Article

References (61)

1. Steen V, Medsger TA, Jr. (2003) Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 48: 516-522.
2. Bull TM (2007) Screening and therapy of pulmonary hypertension in systemic sclerosis. Curr Opin Rheumatol 19: 598-603.
3. Steen VD (1996) Scleroderma renal crisis. Rheum Dis Clin North Am 22: 861-878.
4. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, et al. (1998) Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394: 485-490.
5. Faller DV (1999) Endothelial cell responses to hypoxic stress. Clin Exp Pharmacol Physiol 26: 74-84.
6. Dorfmuller P, Humbert M, Perros F, Sanchez O, Simonneau G, et al. (2007) Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol 38: 893-902.
7. Kawut SM, Taichman DB, Archer-Chicko CL, Palevsky HI, Kimmel SE (2003) Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest 123: 344-350.
8. Fisher MR, Mathai SC, Champion HC, Girgis RE, Housten-Harris T, et al. (2006) Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis Rheum 54: 3043-3050.
9. Cool CD, Kennedy D, Voelkel NF, Tuder RM (1997) Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection. Hum Pathol 28: 434-442.
10. Milano A, Pendergrass SA, Sargent JL, George LK, McCalmont TH, et al. (2008) Molecular subsets in the gene expression signatures of scleroderma skin. PLoS ONE 3: e2696.
11. Gardner H, Shearstone JR, Bandaru R, Crowell T, Lynes M, et al. (2006) Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts. Arthritis Rheum 54: 1961-1973.
12. Whitfield ML, Finlay DR, Murray JI, Troyanskaya OG, Chi JT, et al. (2003) Systemic and cell type-specific gene expression patterns in scleroderma skin. Proc Natl Acad Sci U S A 100: 12319-12324.
13. Bull TM, Coldren CD, Moore M, Sotto-Santiago SM, Pham DV, et al. (2004) Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension. Am J Respir Crit Care Med 170: 911-919.
14. Grigoryev DN, Mathai SC, Fisher MR, Girgis RE, Zaiman AL, et al. (2008) Identification of candidate genes in scleroderma-related pulmonary arterial hypertension. Transl Res 151: 197-207.
15. McGoon MD, Krichman A, Farber HW, Barst RJ, Raskob GE, et al. (2008) Design of the REVEAL registry for US patients with pulmonary arterial hypertension. Mayo Clin Proc 83: 923-931.
16. Launay D, Mouthon L, Hachulla E, Pagnoux C, de Groote P, et al. (2007) Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease. J Rheumatol 34: 1005-1011.
17. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
18. Liu Y, Hayes DN, Nobel A, Marron JS (2008) Statistical Significance of Clustering for High-Dimension, Low-Sample Size Data. Journal of the American Statistical Association 103: 1281-1293.
19. Matsushita Y, Hasegawa M, Matsushita T, Fujimoto M, Horikawa M, et al. (2007) Intercellular adhesion molecule-1 deficiency attenuates the development of skin fibrosis in tight-skin mice. J Immunol 179: 698-707.
20. Franchi L, Eigenbrod T, Munoz-Planillo R, Nunez G (2009) The inflamma-some: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 10: 241-247.
21. Browning JL (2008) Inhibition of the lymphotoxin pathway as a therapy for autoimmune disease. Immunol Rev 223: 202-220.
22. Del Galdo F, Artlett CM, Jimenez SA (2006) The role of allograft inflammatory factor 1 in systemic sclerosis. Curr Opin Rheumatol 18: 588-593.
23. Bae YH, Bae MK, Kim SR, Lee JH, Wee HJ, et al. (2009) Upregulation of fibroblast growth factor-2 by visfatin that promotes endothelial angiogenesis. Biochem Biophys Res Commun 379: 206-211.
24. Weinlander K, Naschberger E, Lehmann MH, Tripal P, Paster W, et al. (2008) Guanylate binding protein-1 inhibits spreading and migration of endothelial cells through induction of integrin alpha4 expression. FASEB J 22: 4168-4178.
25. Ivakhno SS, Kornelyuk AI (2004) Cytokine-like activities of some aminoacyl-tRNA synthetases and auxiliary p43 cofactor of aminoacylation reaction and their role in oncogenesis. Exp Oncol 26: 250-255.
26. Hordijk PL (2006) Regulation of NADPH oxidases: the role of Rac proteins. Circ Res 98: 453-462.
27. Teixeira VH, Jacq L, Moore J, Lasbleiz S, Hilliquin P, et al. (2008) Association and expression study of PRKCH gene in a French Caucasian population with rheumatoid arthritis. J Clin Immunol 28: 115-121.
28. Sacks DG, Okano Y, Steen VD, Curtiss E, Shapiro LS, et al. (1996) Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody. J Rheumatol 23: 639-642.
29. Palmer C, Diehn M, Alizadeh AA, Brown PO (2006) Cell-type specific gene expression profiles of leukocytes in human peripheral blood. BMC Genomics 7: 115.
30. Haider AS, Lowes MA, Suarez-Farinas M, Zaba LC, Cardinale I, et al. (2008) Cellular genomic maps help dissect pathology in human skin disease. J Invest Dermatol 128: 606-615.
31. Duan H, Fleming J, Pritchard DK, Amon LM, Xue J, et al. (2008) Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma. Arthritis Rheum 58: 1465-1474.
32. Andrews BS, Friou GJ, Berman MA, Sandborg CI, Mirick GR, et al. (1987) Changes in circulating monocytes in patients with progressive systemic sclerosis. J Rheumatol 14: 930-935.
33. Varga-Szabo D, Pleines I, Nieswandt B (2008) Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol 28: 403-412.
34. Quarck R, Nawrot T, Meyns B, Delcroix M (2009) C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. J Am Coll Cardiol 53: 1211-1218.
35. Junhui Z, Xingxiang W, Guosheng F, Yunpeng S, Furong Z, et al. (2008) Reduced number and activity of circulating endothelial progenitor cells in patients with idiopathic pulmonary arterial hypertension. Respir Med 102: 1073-1079.
36. Herlitz J, Svensson L (2008) The value of biochemical markers for risk stratification prior to hospital admission in acute chest pain. Acute Card Care 10: 197-204.
37. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D (1992) Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 175: 323-329.
38. Garcovich A, Pagano L, Storti S, Paoletti S, Piscitelli R, et al. (1989) An evaluation of some inflammatory, coagulative and immune factors in progressive systemic sclerosis. Panminerva Med 31: 76-79.
39. Kominato Y, Galson D, Waterman WR, Webb AC, Auron PE (1995) Monocyte expression of the human prointerleukin 1 beta gene (IL1B) is dependent on promoter sequences which bind the hematopoietic transcription factor Spi-1/ PU.1. Mol Cell Biol 15: 58-68.
40. Netea MG, Nold-Petry CA, Nold MF, Joosten LA, Opitz B, et al. (2009) Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 113: 2324-2335.
41. Hirotani T, Yamamoto M, Kumagai Y, Uematsu S, Kawase I, et al. (2005) Regulation of lipopolysaccharide-inducible genes by MyD88 and Toll/IL-1 domain containing adaptor inducing IFN-beta. Biochem Biophys Res Commun 328: 383-392.
42. Perros F, Dorfmuller P, Souza R, Durand-Gasselin I, Mussot S, et al. (2007) Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension. Eur Respir J 29: 462-468.
43. Chomarat P, Banchereau J, Davoust J, Palucka AK (2000) IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol 1: 510-514.
44. Itoh T, Nagaya N, Ishibashi-Ueda H, Kyotani S, Oya H, et al. (2006) Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension. Respirology 11: 158-163.
45. Steiner MK, Syrkina OL, Kolliputi N, Mark EJ, Hales CA, et al. (2009) Interleukin-6 overexpression induces pulmonary hypertension. Circ Res 104: 236-244, 228p following 244.
46. Horvath CJ, Ferro TJ, Jesmok G, Malik AB (1988) Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils. Proc Natl Acad Sci U S A 85: 9219-9223.
47. Wort SJ, Ito M, Chou PC, Mc Master SK, Badiger R, et al. (2009) Synergistic induction of endothelin-1 by tumor necrosis factor alpha and interferon gamma is due to enhanced NF-kappaB binding and histone acetylation at specific kappaB sites. J Biol Chem 284: 24297-24305.
48. Fujita M, Mason RJ, Cool C, Shannon JM, Hara N, et al. (2002) Pulmonary hypertension in TNF-alpha-overexpressing mice is associated with decreased VEGF gene expression. J Appl Physiol 93: 2162-2170.
49. Zhang HG, Hyde K, Page GP, Brand JP, Zhou J, et al. (2004) Novel tumor necrosis factor alpha-regulated genes in rheumatoid arthritis. Arthritis Rheum 50: 420-431.
50. Hasegawa M, Fujimoto M, Kikuchi K, Takehara K (1997) Elevated serum tumor necrosis factor-alpha levels in patients with systemic sclerosis: association with pulmonary fibrosis. J Rheumatol 24: 663-665.
51. Denton CP, Engelhart M, Tvede N, Wilson H, Khan K, et al. (2009) An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis. Ann Rheum Dis 68: 1433-1439.
52. Bargagli E, Galeazzi M, Bellisai F, Volterrani L, Rottoli P (2008) Infliximab treatment in a patient with systemic sclerosis associated with lung fibrosis and pulmonary hypertension. Respiration 75: 346-349.
53. Chaouat A, Savale L, Chouaid C, Tu L, Sztrymf B, et al. (2009) Role for interleukin-6 in COPD-related pulmonary hypertension. Chest 136: 678-687.
54. Savale L, Tu L, Rideau D, Izziki M, Maitre B, et al. (2009) Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice. Respir Res 10: 6.
55. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, et al. (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15: 202-205.
56. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, et al. (2009) ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 119: 2250-2294.
57. Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, et al. (2008) Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 177: 1248-1254.
58. Huang da W, Sherman BT, Tan Q, Collins JR, Alvord WG, et al. (2007) The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol 8: R183.
59. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
60. Farina G, Lemaire R, Pancari P, Bayle J, Widom RL, et al. (2009) Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor beta. Ann Rheum Dis 68: 435-441.
61. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.